Ian Rhodes
2022
In 2022, Ian Rhodes earned a total compensation of $162K as Interim Chief Financial Officer at Akers Biosciences.
Compensation breakdown
| Salary | $162,000 |
|---|---|
| Total | $162,000 |
Rhodes received $162K in salary, accounting for 100% of the total pay in 2022.
Rankings
In 2022, Ian Rhodes' compensation ranked 5,469th out of 5,753 executives tracked by ExecPay. In other words, Rhodes earned more than 4.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,469 out of 5,753 | 5th |
Division Manufacturing | 2,991 out of 3,133 | 5th |
Major group Chemicals And Allied Products | 1,373 out of 1,419 | 3rd |
Industry group Drugs | 1,281 out of 1,320 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 29 out of 29 | 0th |
Source: SEC filing on November 1, 2024.
Rhodes' colleagues
We found three more compensation records of executives who worked with Ian Rhodes at Akers Biosciences in 2022.